This content is from:APP亚博娱乐
GSK Finalizes PE Firms For Assets Sale
GlaxoSmithKline has shortlisted a group of private equity funds and strategic bidders for the sale of its non-core over-the-counter products.
GlaxoSmithKline(GSK) has shortlisted a group of private equity funds and strategic bidders for the sale of its non-core over-the-counter products. The bidders include private equity fundsBain Capital,Blackstoneand German pharmaceutical groupBoehringer Ingelheim.
The sale will fetch the U.K. pharmaceutical company an estimated £1.5 billion. Other interested firms includeThomas H. Lee Partners,Bayer Groupand Brussels-listed pharmaceutical companyOmega Pharma. Final-round bids are likely to be tendered at the end of September or early October. The process is being managed byGoldman Sachs.
Click here for the story fromFinancial Times.
Click here for additional coverage fromReuters.